Osmotica Pharmaceutical is a fully-integrated pharmaceutical company specializing in osmotic drug delivery. The Company possesses a diversified product portfolio in the specialty neurology and women's health space, including five promoted products and approximately 35 non-promoted products, several of which incorporate the proprietary Osmodex® drug delivery system. The non-promoted product portfolio includes methylphenidate HCl ER tablets and venlafaxine HCl ER tablets and prescription and non-prescription dietary supplements.